Dimension (range) | Cilazapril (n = 161)2-150 | Captopril (n = 77)2-150 | Placebo/cilazapril (n = 72)2-150 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | Change 12–0 | Change 24–12 | Baseline | Change 12–0 | Change 24–12 | Baseline | Change 12–0 | Change 24–12 | |||
Tension-anxiety | 8.42 | −1.14 | −0.18 | 8.87 | −0.78 | +0.01 | 9.81 | −0.85 | −1.12 | ||
(0–32) | (0.32) | (0.27) | (0.42) | (0.42) | (0.56) | (0.53) | |||||
Depression-dejection | 6.26 | −1.22 | −0.24 | 7.54 | −2.22 | +1.02 | 7.85 | −0.45 | −1.09 | ||
(0–47) | (0.40) | (0.44) | (0.81) | (0.77) | (0.94) | (0.76) | |||||
Anger-hostility | 4.86 | −0.43 | −0.23 | 5.06 | −0.34 | −0.38 | 6.28 | −0.17 | −0.70 | ||
(0–41) | (0.33) | (0.32) | (0.50) | (0.47) | (0.76) | (0.69) | |||||
Vigour-activity | 13.48 | +0.54 | +0.41 | 12.06 | +0.57 | −0.32 | 12.45 | +0.67 | +0.98 | ||
(0–32) | (0.45) | (0.38) | (0.46) | (0.50) | (0.65) | (0.51) | |||||
Fatigue-inertia | 6.99 | −1.13 | -0.73 | 7.87 | −1.90 | +0.09 | 7.66 | −1.09 | −1.01 | ||
(0–26) | (0.39) | (0.26) | (0.57) | (0.51) | (0.65) | (0.58) | |||||
Confusion-bewilderment | 5.67 | −0.92 | 0 | 6.19 | −0.83 | +0.01 | 6.19 | −0.43 | −0.57 | ||
(0–22) | (0.25) | (0.20) | (0.36) | (0.32) | (0.46) | (0.32) | |||||
Total | 51.13 | −5.46 | −1.91 | 55.57 | −7.34 | +1.08 | 57.70 | −3.56 | −5.77 | ||
(0–149) | (1.41) | (1.30) | (2.44) | (2.16) | (3.01) | (2.48) |
A high score indicates a poor QOL (except for vigour-activity).
↵2-150 Number of patients providing information at both 0 and 12 weeks.